Inhibikase Therapeutics (IKT) Return on Assets [ROA] (2021 - 2026)
Inhibikase Therapeutics (IKT) recorded Return on Assets [ROA] of -38.84% in Q2 2026, up 9.41 percentage points from -48.26% a year earlier but down 7.69 percentage points from the prior quarter.
Powered by 
Analysis
Inhibikase Therapeutics (IKT) Return on Assets [ROA] (2021 - 2026) Analysis & Trends
For FY2025, Inhibikase Therapeutics reported Return on Assets [ROA] of -37.15%, up 13.40 percentage points from FY2024.
- Annual Return on Assets [ROA] has a four-year change of +14.50 percentage points (FY2021 to FY2025).
- Across earlier years, Return on Assets [ROA] came in at -50.55% in FY2024 (+51.32 pp), -101.87% in FY2023 (-48.08 pp), -53.79% in FY2022 (-2.14 pp) and -51.65% in FY2021.
- Quarterly Return on Assets [ROA] has ranged from -303.91% in Q3 2024 to -23.04% in Q3 2021 over the past five years.
- On a year-over-year basis, Return on Assets [ROA] has increased for seven consecutive quarters, with an average year-over-year change of +50.22 percentage points over the last eight quarters.
- Peak year-over-year performance for Return on Assets [ROA] in the last five years was a gain of 243.21 percentage points in Q3 2025, against a drop of 204.38 percentage points in Q3 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at -31.15% (Q1 2026), -39.86% (Q4 2025) and -60.70% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 19.00% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 7.32% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.87% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.36% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 9.80% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -7.67% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 2.00% |
| 10 | Inhibikase Therapeutics | 281.11 Mn | -420.36 Mn | - | -10,750,375.81% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -10,750,375.81% |
| Jun 30, 2026 | -11,657,179.25% |
| Mar 31, 2026 | -5,594,647.81% |
| Dec 31, 2025 | -7,605,501.64% |
| Sep 30, 2025 | -11,775,208.05% |
| Jun 30, 2025 | -10,830,868.87% |
| Mar 31, 2025 | -5,141,884.65% |
| Dec 31, 2024 | -9,631,020.59% |
| Sep 30, 2024 | -75,113,138.66% |
| Jun 30, 2024 | -49,850,428.20% |
| Mar 31, 2024 | -151.46% |
| Dec 31, 2023 | -118.15% |
| Sep 30, 2023 | -95.24% |
| Jun 30, 2023 | -75.35% |
| Mar 31, 2023 | -66.76% |
| Dec 31, 2022 | -67.08% |
| Sep 30, 2022 | -60.06% |
| Jun 30, 2022 | -51.93% |
| Mar 31, 2022 | -41.53% |
| Dec 31, 2021 | -33.48% |
API Access
Inhibikase Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=IKT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "IKT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=IKT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();